MedTrace Logo

Clinical Evaluation of an IGRA Test for the Diagnosis of Active and Latent Tuberculosis

NCT06485895 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 500

Last updated 2024-08-01

No results posted yet for this study

Summary

Methodology This is a single-center study carried out as part of routine patient care.

The aim of the study is to determine the performance of the 2nd generation TB-IGRA test in the diagnosis of tuberculosis.

Conditions

Interventions

DIAGNOSTIC_TEST

test IGRA

BLOOD SAMPLES

DIAGNOSTIC_TEST

TEST QUATIFERON TB Gold Plus

BLOOD SAMPLES

Sponsors & Collaborators

  • Assistance Publique Hopitaux De Marseille

    lead OTHER

Principal Investigators

  • François CREMIEUX · ASSISTANCE PUBLIQUE HOPITAUX D EMARSEILLE

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-30
Primary Completion
2027-07-30
Completion
2028-02-01

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06485895 on ClinicalTrials.gov